Literature DB >> 20437212

Clinical trials report: optimal treatment of Helicobacter pylori gastric infection in children.

Susan R Orenstein1.   

Abstract

Entities:  

Year:  2010        PMID： 20437212     DOI： 10.1007/s11894-010-0099-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  11 in total

Review 1.  Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori.

Authors:  B Drumm; S Koletzko; G Oderda
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-02       Impact factor: 2.839

2.  A review of current guidelines for the management of Helicobacter pylori infection in children and adolescents.

Authors:  Nicola L Jones
Journal:  Paediatr Child Health       Date:  2004-12       Impact factor: 2.253

3.  A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.

Authors:  Bradford D Gessner; Michael G Bruce; Alan J Parkinson; Benjamin D Gold; Pam T Muth; Eitel Dunaway; Henry C Baggett
Journal:  Clin Infect Dis       Date:  2005-10-04       Impact factor: 9.079

4.  A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.

Authors:  H Shashidhar; J Peters; C H Lin; R Rabah; R Thomas; V Tolia
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-03       Impact factor: 2.839

Review 5.  Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation.

Authors:  Billy Bourke; Peter Ceponis; Naoki Chiba; Steve Czinn; Richard Ferraro; Lori Fischbach; Ben Gold; Hien Hyunh; Kevan Jacobson; Nicola L Jones; Sibylle Koletzko; Sylvie Lebel; Paul Moayyedi; Robert Ridell; Philip Sherman; Sander van Zanten; Ivan Beck; Linda Best; Margaret Boland; Ford Bursey; Hugh Chaun; Geraldine Cooper; Brian Craig; Carole Creuzenet; Jeffrey Critch; Krishnasamy Govender; Eric Hassall; Alan Kaplan; Monica Keelan; Garth Noad; Marli Robertson; Lesley Smith; Markus Stein; Diane Taylor; Thomas Walters; Robin Persaud; Scott Whitaker; Robert Woodland
Journal:  Can J Gastroenterol       Date:  2005-07       Impact factor: 3.522

6.  Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?

Authors:  Joseph Faber; Maskit Bar-Meir; Bernard Rudensky; Yechiel Schlesinger; Elena Rachman; Shmuel Benenson; Gisela Sirota; Halina Stankiewic; David Halle; Michael Wilschanski
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-05       Impact factor: 2.839

7.  Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.

Authors:  Shahla Bahremand; Laleh Razavi Nematollahi; Hossein Fourutan; Faroukh Tirgari; Shamsollah Nouripour; Elham Mir; Shahriar Aghakhani
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 2.566

8.  Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.

Authors:  Jungi Choi; Joo Young Jang; Joon Sung Kim; Hwa Young Park; Yon Ho Choe; Kyung Mo Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

9.  Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.

Authors:  Giuseppina Oderda; Daniela Marinello; Pietro Lerro; Maria Kuvidi; Gian Luigi de'Angelis; Anna Ferzetti; Salvatore Cucchiara; Maria Teresa Franco; Claudio Romano; Pietro Strisciuglio; Lucia Pensabene
Journal:  Helicobacter       Date:  2004-08       Impact factor: 5.753

10.  Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.

Authors:  Seyed Mohsen Dehghani; Asma Erjaee; Mohammad Hadi Imanieh; Mahmood Haghighat
Journal:  Dig Dis Sci       Date:  2008-11-14       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.